By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
Rylo Health review
Quarterly charge shown upfront
Rylo’s homepage lists quarterly charges of $299 for compounded semaglutide and $479 for compounded tirzepatide.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
Rylo’s homepage lists quarterly charges of $299 for compounded semaglutide and $479 for compounded tirzepatide.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How Rylo Health publishes its prices
Quarterly plans bill $299 and $479 every three months, respectively. The displayed $100 and $160 monthly equivalents are rounded. Two charges at the listed amounts would total $598 and $958.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What Rylo Health is
Rylo Health offers online prescription evaluation and advertises compounded injection options.
How it works
Its homepage advertises consistent refill rates and cancellation without a fee. Check the refund terms for a quarter already billed.
Branded or compounded
Rylo identifies compounded semaglutide and compounded tirzepatide. Compounded medications are not FDA-approved.
Where the money holds, and where it moves
Predictable
- Publishes the full quarterly charge
Moves, or is not stated
- Monthly equivalents require quarterly billing
Who this is worth it for
People who want to compare a quarterly bill against per-fill pricing.
Who should price elsewhere
People who prefer a single-month purchase over quarterly billing.
The molecules
What Rylo Health prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside Rylo Health
SignosPeople evaluating the sensor and medication offer together.
See Signos →Science & Co
Buyers who obtain the full commitment and renewal terms in writing
See Science & Co →
Ryze RxPeople who can confirm their plan total and renewal date before enrolling.
See Ryze Rx →
More GLP-1 sellers by price priced end to end: HealthSourceHeliMedsHello AlphaHelloWellnessHenry MedsHeros Health
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Does Rylo charge $100 every month for the advertised semaglutide plan?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare Rylo Health against every seller on it.